what did rfk say about tylenol

Robert F. Kennedy Jr., the U.S. Health and Human Services Secretary, stated that the FDA will begin the process of changing the safety label on Tylenol (acetaminophen) and initiate a public awareness campaign about its use during pregnancy. He mentioned that clinical and laboratory studies suggest a potential association between acetaminophen use during pregnancy and adverse neurodevelopmental outcomes, including autism, although the National Institutes of Health (NIH) research teams are still testing multiple hypotheses. Kennedy indicated that acetaminophen should only be prescribed during pregnancy when medically necessary, such as for high fever, as part of a cautious approach due to these potential risks. Kennedy's position was made alongside President Trump, who warned against the use of Tylenol during pregnancy, claiming increased autism risk, although these claims are controversial and have been met with strong opposition from many in the medical and scientific community. The FDA and other experts stress that no causal link has been definitively established, and acetaminophen remains one of the safest pain relievers for pregnant women when used appropriately. In summary, RFK Jr. is advocating for stricter guidance on Tylenol use in pregnancy based on a suggested potential risk of autism, but this is not yet confirmed by conclusive scientific evidence and remains debated among health professionals.